TrialDiabetes, obesity & metabolism2014

Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial.

C S Kovacs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.